Clinical Trials Directory

Trials / Unknown

UnknownNCT06191822

Aspire2B Personalization Pilot Study Program

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
3,000 (estimated)
Sponsor
PepsiCo Global R&D · Industry
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Accepted

Summary

This non-randomized pilot study program is focused on assessing the technical characteristics of the Aspire2B mobile device application.

Detailed description

Aspire2B is a mobile wellness app that uses non-invasive measurements to predict various physiological states and estimate biological age. Users are then enrolled in nutrition, fitness, or sleep challenges within the app that are aimed at improving overall wellness and thus helping to reduce biological age. Mobile health (mHealth) interventions require numerous decisions that integrate behavioral theory, user feedback, and technical and practical feasibility considerations. The main purpose of this research program is to test if the application works as intended. This pilot study program is managed internally by Pepsico clinical researchers.

Conditions

Interventions

TypeNameDescription
OTHERNutritionInteract with mobile app and work toward personalized nutrition goals
OTHERFitnessInteract with mobile app and work toward personalized fitness goals
OTHERSleepInteract with mobile app and work toward personalized sleep goals

Timeline

Start date
2022-03-01
Primary completion
2024-06-30
Completion
2024-06-30
First posted
2024-01-05
Last updated
2024-01-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06191822. Inclusion in this directory is not an endorsement.